Daliresp Roflumilast 500 mcg Tablets - Chronic COPD Treatment
USAMP#73116234SKU: 00310009530Daliresp®
License Required
Product Spotlight
- Contains Roflumilast 500 mcg, a potent Phosphodiesterase Type 4 Inhibitor, designed to treat symptoms of chronic obstructive pulmonary disease (COPD).
- Manufactured by AstraZeneca Pharmaceuticals, ensuring high-quality and reliable medication for COPD management.
- Each bottle contains 30 tablets, specifically formulated for oral administration.
- Prescription medication that targets the underlying inflammation in the lungs, improving lung function and reducing exacerbations in severe COPD patients.
- Latex-free product, suitable for patients with latex allergies.
- Ensure to store in a cool, dry place to maintain efficacy and shelf-life.
